KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Interest & Investment Income: 2018-2024

Historic Interest & Investment Income for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Dec 2024 value amounting to $17.0 million.

  • Aurinia Pharmaceuticals' Interest & Investment Income fell 22.29% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year decrease of 19.87%. This contributed to the annual value of $17.0 million for FY2024, which is 0.16% down from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Interest & Investment Income of $17.0 million as of FY2024, which was down 0.16% from $17.0 million recorded in FY2023.
  • Aurinia Pharmaceuticals' Interest & Investment Income's 5-year high stood at $17.0 million during FY2023, with a 5-year trough of $529,000 in FY2021.
  • Over the past 3 years, Aurinia Pharmaceuticals' median Interest & Investment Income value was $17.0 million (recorded in 2024), while the average stood at $13.0 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 65.11% in 2021, then skyrocketed by 867.49% in 2022.
  • Over the past 5 years, Aurinia Pharmaceuticals' Interest & Investment Income (Yearly) stood at $1.5 million in 2020, then slumped by 65.11% to $529,000 in 2021, then spiked by 867.49% to $5.1 million in 2022, then skyrocketed by 232.10% to $17.0 million in 2023, then declined by 0.16% to $17.0 million in 2024.